S. Difuntorum

DNA binding ligands targeting drug-resistant Gram-positive bacteria. Part 2: C-terminal benzimidazoles and derivatives.

R. Bürli, D. McMinn, Jianxin Duan, 2004, Bioorganic & medicinal chemistry letters.

In Vitro Antimicrobial Activity of GSQ1530, a New Heteroaromatic Polycyclic Compound

R. Bürli, I. Critchley, H. Moser, 2002, Antimicrobial Agents and Chemotherapy.

In Vitro Activity of Telavancin against Resistant Gram-Positive Bacteria

K. Krause, D. Debabov, Terry Wu, 2008, Antimicrobial Agents and Chemotherapy.

DNA binding ligands with improved in vitro and in vivo potency against drug-resistant Staphylococcus aureus.

Kirk W. Johnson, R. Bürli, B. Bozdoğan, 2004, Journal of medicinal chemistry.

Efficacy of telavancin against glycopeptide-intermediate Staphylococcus aureus in the neutropenic mouse bacteraemia model.

K. Krause, S. Hegde, R. Skinner, 2009, The Journal of antimicrobial chemotherapy.

Efficacy of telavancin in a murine model of pneumonia induced by methicillin-susceptible Staphylococcus aureus.

S. Hegde, R. Skinner, Noe Reyes, 2007, The Journal of antimicrobial chemotherapy.

In vitro antibacterial activity of the peptide deformylase inhibitor BB-83698.

Kirk W. Johnson, J. Clements, J. Karlowsky, 2004, The Journal of antimicrobial chemotherapy.

Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.

J. Clements, K. Johnson, U. Hoch, 2004, The Journal of antimicrobial chemotherapy.